These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 1398412)
21. Effect of gemfibrozil on erythrocyte membrane lipids in geriatric patients. Bauer M; Platt D; Hager K Exp Gerontol; 1990; 25(1):37-46. PubMed ID: 2318281 [TBL] [Abstract][Full Text] [Related]
22. Cholesterol and prostate cancer. Harv Mens Health Watch; 2011 Jun; 15(11):6-7. PubMed ID: 21706781 [No Abstract] [Full Text] [Related]
23. Molecular mechanisms of lipid disorders in nephrotic syndrome. Vaziri ND Kidney Int; 2003 May; 63(5):1964-76. PubMed ID: 12675893 [No Abstract] [Full Text] [Related]
24. Cholesterol and chloroquine. Borba EF Rev Bras Reumatol; 2011 Dec; 51(6):673. PubMed ID: 22124601 [No Abstract] [Full Text] [Related]
25. Safety of combined pravastatin-gemfibrozil therapy. Rosenson RS; Frauenheim WA Am J Cardiol; 1994 Sep; 74(5):499-500. PubMed ID: 8059735 [No Abstract] [Full Text] [Related]
26. [Metabolism of magnesium and lipid disturbances in chronic renal failure]. Fijałkowska-Morawska J; Chrzanowski W Pol Arch Med Wewn; 1997 Oct; 98(10):327-31. PubMed ID: 9557087 [No Abstract] [Full Text] [Related]
34. Further evidence of favorable effects of gemfibrozil on the lipid profile in renal allograft recipients. Ok E; Kursat S; Alev M; Tobu M; Tokat Y; Akcicek F; Hoscoskun C; Basci A Nephron; 1996; 73(3):491-2. PubMed ID: 8832618 [No Abstract] [Full Text] [Related]
36. Rethinking cholesterol management. Lowering LDL levels is once again the Holy Grail, since raising HDL failed to make a difference after all. Duke Med Health News; 2013 Mar; 19(3):3. PubMed ID: 27024483 [No Abstract] [Full Text] [Related]
37. ANGPTL3 targeting: The power of versatile lipid-lowering. Pessentheiner AR; Ramms B; Gordts PLSM Atherosclerosis; 2018 Jan; 268():185-187. PubMed ID: 29111225 [No Abstract] [Full Text] [Related]
38. [Gemfibrozil in the differential therapy of disorders of fat metabolism]. Ebner F Fortschr Med; 1992 Oct; 110(28):523-6. PubMed ID: 1398412 [TBL] [Abstract][Full Text] [Related]
39. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins. Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787 [TBL] [Abstract][Full Text] [Related]
40. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels. Weis S; Kudchodkar BJ; Clearfield MB; Lacko AG Artery; 1992; 19(6):353-66. PubMed ID: 1471924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]